Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-24
2007-04-24
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S312000, C546S307000, C546S304000, C546S290000, C514S345000
Reexamination Certificate
active
11056777
ABSTRACT:
The invention relates to pyridines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity and/or proliferation of cells such as tumor cells.
REFERENCES:
patent: 3119823 (1964-01-01), Shapiro
patent: 3933814 (1976-01-01), Haberkorn et al.
patent: 3948893 (1976-04-01), Aichinger et al.
patent: 3966725 (1976-06-01), Reisdorff et al.
patent: 4219552 (1980-08-01), Haberkorn et al.
patent: 4499269 (1985-02-01), Bennion et al.
patent: 5102927 (1992-04-01), Rody et al.
patent: 5260362 (1993-11-01), Rody et al.
patent: 5545836 (1996-08-01), Reinehr et al.
patent: 5702717 (1997-12-01), Cha et al.
patent: 5856331 (1999-01-01), Bursten et al.
patent: 6004985 (1999-12-01), Kochanny et al.
patent: 6150360 (2000-11-01), Daeyaert et al.
patent: 6150362 (2000-11-01), Henkin et al.
patent: 6150382 (2000-11-01), Kochanny et al.
patent: 6166014 (2000-12-01), Kochanny et al.
patent: 6193960 (2001-02-01), Metzger et al.
patent: 6288228 (2001-09-01), Henkin et al.
patent: 1200314 (1965-09-01), None
patent: 2226474 (1973-02-01), None
patent: 525 262 (1993-02-01), None
patent: 1321624 (1963-03-01), None
patent: 48-28486 (1973-04-01), None
patent: 49-69688 (1974-07-01), None
patent: 274102 (1970-04-01), None
patent: WO 91/11465 (1991-08-01), None
patent: WO 00/25780 (2000-05-01), None
patent: WO 01/25220 (2001-04-01), None
patent: WO 02/22584 (2002-03-01), None
patent: WO 02/36578 (2002-05-01), None
Butler, D.E. et al.: Novel pharmacological activity of a series of substituted pyridines. J. Med. Chem. vol. 14, pp. 575-579, 1971.
Compounds with RN 417724-78-8 and 417721-23-4, published in WO 02/32872, Apr. 25, 2002.
Anonymous, “Inhibiting LPAAT-β slows tumor growth in animal models,”Hematological Oncology Today, Feb. 3, 2003, p. 45.
Britten and Kohne, “Repeated Sequences in DNA,”Science 161(3841): 529-540, Aug. 9, 1968.
Brodskii et al., “The mechanism underlying the action of secondary aromatic amine- type antioxidants and their ethers on the radiation oxidation of N-butylpropionamide and polycaproamide,”Chemical Abstracts, Accession No. 69:3284, 1968.
Budesinsky et al., “Substituted 2, 4-diamino-6-phenyl-1,3,5-triazines,”Chemical Abstracts, Accession No. 97:6328, 1982.
Burmistrov et al., “6-Amino-4-arylamino-2-(o-hydroxyphenyl) triazines,”Chemical Abstracts, Accession No. 61:47941, 1964.
Burnsten et al., “Interleukin-1 Rapidly Stimulates Lysophosphatidate Acyltransferase and Phosphatidate Phosphohydrolase Activities in Human Mesangial Cells,”Journal of Biological Chemistry 266(31): 20732-20743, Nov. 5, 1991.
Bursten et al., “Lipid A activation of glomerular mesangial cells: mimicry of the bioactive lipid, phosphatidic acid,”American Journal of Physiology 262(2): C328-C338, Feb. 1992.
Chen, C. et al., “A Convenient Synthetic Method for Trisubstituted s-Triazines,”Chemical Abstracts, Accession No. 124:146076, 1995.
Compounds with RN 545396-39-2, RN 34891-38-8 and RN 19933-09-6.
Eberhardt et al., “Human Lysophosphatidic Acid Acyltransferase,”Journal of Biological Chemistry 272(32): 20299-20305, Aug. 8, 1997.
Elkafrawy, A.F. et al., “Synthesis and reactions of some 4-aryl-2-benzylthio-1, 6-dihydro-6-thiono-1,3,5-triazines,”Chemical Abstracts, Accession No. 115:279963, 1991.
English, D., “Phosphatidic acid: A lipid messenger involved in intracellular and extracellular signaling,”Cell Signal 8(5): 341-347, 1996.
Fong and Engleman, “Dendritic Cells in Cancer Immunotherapy,”Annual Review of Immunology 18: 245-273, 2000.
Fusco, R. et al., “Reaction of arylazochloroacetic esters with tertiary cyclic bases,”Gazzetta Chimica Italiana 98(5): 511-534, 1968. English Translation.
Haviv, F. et al., “2-[(Phenylthio)methyl]pyridine Derivaties: New Antiinflamatory Agents,”J. Med. Chem. 26: 218-222, 1983.
Hoess and Abremski, “The Cre-lox Recombination System,”Nucleic Acids and Molecular Biology 4: 99-109, 1990.
Imamura et al, “Induction ofin vitrotumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D,”Biochemical and Biophysical Research Communications 193(2): 497-503, Jun. 15, 1993.
Kester, M., “Platelet-Activating Factor Stimulates Phosphatidic Acid Formation in Culture Rat Mesangial Cells: Roles of Phospholipase D, Diglyceride Kinase, and De Novo Phospholipid Synthesis,”Journal of Cellular Physiology 156: 317-325, 1993.
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature 256: 495-497, Aug. 7, 1975.
Kume and Shimizu, “cDNA Cloning and Expression of Murine 1-Acyl-sn-glycerol-3-phosphate Acyltransferase,”Biochemical and Biophysical Research Communications 237(3): 663-666, Aug. 28, 1997.
Leung et al., “Molecular Cloning of Two Alternatively Spliced Forms of Human Phosphatidic Acid Phosphatase cDNAs that Are Differentially Expressed in Normal and Tumor Cells,”DNA and Cell Biology 17(4): 377-385, Apr. 1998.
Losman et al., “Baboon anti-idiotype antibodies mimic a carcinoembryonic antigen epitope,”Int. J. Cancer 46(2): 310-314, Aug. 15, 1990.
Martin et al., “Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts,”Oncogene 14(13):1571-1580, Apr. 3, 1997.
Michalik, M. et al., “Synthesis of nitrogen-containing heterocycles,”Chemical Abstracts, Accession No. 79:18680, 1973.
Miller and Rosman, “Improved Retroviral Vectors for Gene Transfer and Expression,”BioTechniques 7(9): 980-EOA, Oct. 1989.
Moolenaar, W.H., “Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger,”Journal of Biological Chemistry 270(22): 12949-12952, Jun. 2, 1995.
Moussa, G.E.M. et al., “Some reactions on 4-aryl-2-substituted amino-1,6-dihydro-6-thioxo-1,3,5 triazines,”Chemical Abstracts, Accession No. 113:59112, 1990.
Orlandi et al., “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction,”Proc. Natl. Acad. Sci. USA 86(10): 3833-3837, May 1989.
Pitts et al., “Rapid Synthesis of Triazine Inhibitors of Inosine Monophoshate Dehydrogenase,”Bioorganic & Medicinal Chemistry Letters 12: 2137-2140; 2002.
Prostakov, N.S. et al., “Substituted Pyridines. 5-Methyl-4-Phenyl-2-(Aminoalkoxy, Aroxymethyl)pyridines,”Chemistry of Heterocyclic Compounds 7(9): 1137-1138, Sep. 1971.
Rizzo et al., “The Recruitment of Raf-1 to Membranes Is Mediated by Direct Interaction with Phosphatidic Acid and Is Independent of Association with Ras,”Journal of Biological Chemistry 275(31): 23911-23918, Aug. 4, 2000.
Sauer, B., “Inducible Gene Targeting in Mice Using the Cre/loxSystem,”Methods: A Companion to Methods in Enzymology 14(4): 381-392, Apr. 1998.
Schreurs et al., “Dendritic Cell-Based Vaccines: From Mouse Models to Clinical Cancer Immunotherapy,”Critical Reviews in Oncogenesis 11(1): 1-17, 2000.
Shapiro, S.L. et al., “Guanamines. VIII. 6-(Substituted-phenyl) guanamines,”Chemical Abstracts, Accession No. 56:60602, 1962.
Sharp et al., “Viral DNA in Transformed Cells. I.A Study of the Sequences of Adenovirus 2 DNA in a Line of Transformed Rat Cells Using Specific Fragments of the Viral Genome,”J. Mol. Biol. 86(4): 709-726, Jul. 15, 1974.
Sluka et al., “2,4-diamino-6-phenyl-1,3,5-triazines,”Collection Czechoslov. Chem. Commun. 43: 1639-1646, 1978.
Stamps et al., “A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases,”Biochemical Journal 326:455-461, Sep. 1, 1997.
Sutton, W.D., “A crude nuclease preparation suitable for use in DNA reassociation experiments,”Biochimica et Biophysica Acta 240(4): 522-531, Jul. 29, 1971.
West et al., “Cloning and Expression of Two Human L
Hong Feng
Klein J Peter
Aulakh Charanjit S.
Cell Therapeutics Inc.
Seed IP Law Group PLLC
LandOfFree
Pyridines and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridines and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridines and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753960